Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The pressure is building!
DCGN News.
deCODE Reinstated to Nasdaq Global Market PR Newswire "US Press Releases "
REYKJAVIK, Iceland , June 26 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq:DCGN) today announced that it has received notice from the the Nasdaq Hearing and Listing Review Council that the listing of the company's common stock will be reinstated to the Nasdaq Global Market effective from the opening of trading on Monday, June 29 . deCODE's common stock will continue to trade under the symbol DCGN.
The reinstatement follows the Listing Council's reversal of a decision in February by the Nasdaq Listing Qualifications Panel under which the listing of deCODE's common stock was transferred to the Nasdaq Capital Market .
About deCODE
deCODE is a bio-pharmaceutical company developing drugs and DNA-based tests to improve the treatment, diagnosis and prevention of common diseases. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader in human genetics, and has identified key variations in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProstateCancer(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for the common forms of breast cancer. deCODE is delivering on the promise of the new genetics.SM Visit us on the web at http://www.decode.com; on our diagnostics site at http://www.decodediagnostics.com; for our pioneering personal genome analysis service and new focused disease scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, as well as for our new deCODEme Cardio(TM) and deCODEme Cancer(TM) scans, at http://www.decodeme.com; and on our blog at http://www.decodeyou.com.
Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission , including, without limitation, the risk factors identified in our most recent Annual Report on Form 10-K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.
Contacts: deCODE genetics Edward Farmer +44-7796-010107 edward.farmer@decode.is Gisli Arnason +354-570-1900 gisli.arnason@decode.is Joy Bessenger +1-212-481-3891 joy.bessenger@decode.is
SOURCE deCODE genetics
hopefully todays can't means a bottom, but it broke out of the downword channel. We'll see in the next few days if it was or not. Not sure why people are selling still. Unless it's all the impatient people that bought on the bounce the first day slowly dwindling away.
Once we get confirmation of a bottom will be great to average down.
Jumped on INSM at 1.02 for a bounce play. Still holding, it was down 56% on some "bad" news.
Jumped into Loniees WNR at 6.98. Nice call
Still holding SVA, looking like it might explode soon
Indeed, notice the volume is getting lowre and trading is getting tight... and it's still closing green!
Did you e-mail somethign they didnt' like?
SVA is getting tight!!!
what caused the sell off?
Loniee helped me find a few more supports that have been added, it's at a huge support area
Tell me what you think of the new chart posted in the IBOX before you go telling people to sell..... and for anyone that doesn't know, this one is short.
UPDATED SVA CHART: Nothing that I see. Support is holding just fine and it's continuously testing that $4. You can see it's getting crammed into a wedge and if it is goign to continue it's uptrend, it might break out w/in the next 3 days... If not, you have about 4-6 days of sideways trading before the lower trendline catches up. The only thing is the PPO and MACD are about to cross south, while the FULL sto and the SLOW sto cross north. Maybe someone with a little more experience can comment on this one...Loniee?
It is pretty funny isn't it. These people screaming dilution haven't even bothered to read any of today's posts or the NEW sticky note with a chart that pretty much proves there is no dilution!!
Perhaps, but the chart is looking like it's running out of downward steam. All it takes is "they get to keep the treasure news" and this thing shoots to a new 52 week high. The only question is, how long are people willing to wait and average down? IMO the chart doesn't have that much further to drop, but i could be wrong. I still believe they will be awarded some, if not all of the treasure.
ATTN ALL: OMCY has hit my .72 alert. A break of .73 would be a key indicator! All indicators pointing up.
The only thing is...VOLUME SUCKS!!!!!!!!! Would not want to drop too much in and not be able to get out lol.
Chart
GNVC chart. Looks like it bounced off support possibly for a next leg up. Gonna take a lot for it to drop below the 50/200 ma.
hey, ya sorry i was still in bed lol.
Poppped over $4 againt his morning eh? Good sign. Another good sign, is support held. We'll see what the eod brings. I'm still in.
thinking about it.... I might put a bid in tomorrow morning and see if it gets filled.
partner sounds kinda.................ghey lol
SVA close at 3.90. Nice.
Everything else.....................OUCH... I new I shoulda got into faz last week.
Are you guys ever happy with the weather? Seems like just yesterday you were all bitching about how cold it was, now it's too hot. Humans are funny, we are never happy lol
well the 3.90 didn't last long, hopefully we break that into the close. Still green and still looking good! A lot of uncertainity in the market now.
I washed my truck with a spongetech sponge this weekend. It was better than I thought it would be, and i'll actually buy it again. I hadn't washed my truck in over 6 months and it only took 5 mins.
Just an FYI, and yes, I'm an investor. Not everyday you find a bb where you can try the product yourself
3.90 new support in the 5 min. Let's break $4 today and close. That would make my blood red monday!
Chart... looks good guys. Keeping an eye on this one... MACD and PPO seperating today
as long as support holds we are fine. This stock is still in an uptrend since march and has shot up many times. With the latest news and giant orders being put through, I can't beleive it would break it's current uptrend. A $4 hold is going to be the key break. I'm looking to hold this one till friday or next week, maybe longer.
SVA, added on dips, now loaded and looking forward to the rest of the week. Guess i'm the only posting here lol
In SVA @ 3.86
Can you say a nice run this week???
Thanks! I love being a dad!
Mondays play! News chart and more! Literally, it's highest volume day ever was friday!
This was posted in my watch list but I looked up some more information on it.
Sinovac Receives China's First Influenza A (H1N1) Vaccine Order
Friday 06/19/2009 10:00 AM ET - Pr Newswire
Related Companies
Symbol Last %Chg
SVA 3.65 0.83%
As of 4:01 PM ET 6/19/09
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that the Company received the first order in China to supply its influenza A (H1N1) vaccine to the Beijing government. The initial order consists of 4 million doses and is expected to be delivered by the end of September. This order will be administered to 2 million people in the high risk group. Additional orders are expected beginning in October and, in total, Sinovac expects to supply approximately 10 million doses to the Beijing government. The 10 million doses will be administered to 5 million people in Beijing.
On June 14, 2009, Sinovac completed construction of the H1N1 virus seed bank necessary to produce a virus antigen and commenced production of the first batch of H1N1 vaccine. Sinovac expects to complete production of the first batch by the end of July.
Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are organizing and coordinating all personnel and resources to produce the H1N1 vaccine, as we have almost completed the production of our seasonal influenza vaccine. With the support and instruction of the relevant government and health authorities, Sinovac will fully utilize its proven development and production abilities from both the H5N1 vaccine and seasonal flu vaccine to ensure the efficient production of the H1N1 vaccine. We are working closely with authorities in order to contribute to the prevention and control of the H1N1 epidemic situation."
About Sinovac
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis vaccine, and human rabies vaccine. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For more information, please contact:
Helen G. Yang
Sinovac Biotech Ltd.
Tel: +86-10-8289-0088 x9871
Fax: +86-10-6296-6910
Email: info@sinovac.com
Investors:
Amy Glynn/Sara Pellegrino
The Ruth Group
Tel: +1-646-536-7023/7002
Email: aglynn@theruthgroup.com
spellegrino@theruthgroup.com
Media:
Janine McCargo
The Ruth Group
Tel: +1-656-536-7033
Email: jmccargo@theruthgroup.com
SOURCE Sinovac Biotech Ltd.
**************************************************************
Sinovac completes construction of flu virus seed bank
Tuesday 06/16/2009 1:12 PM ET - Datamonitor
Related Companies
Symbol Last %Chg
SVA 3.65 0.83%
As of 4:01 PM ET 6/19/09
Sinovac Biotech, a developer and provider of vaccines in China, has completed the construction of the H1N1 virus seed bank necessary to produce a virus antigen.
Sinovac has received the seed virus from the US Center for Disease Control on June 8, 2009 and started the H1N1 vaccine production on the same day. Sinovac expects to complete production of the first batch and initiate clinical trials of an H1N1 vaccine by the end of July 2009.
Sinovac's production of Anflu for the 2009/2010 Northern Hemisphere influenza season is nearly completed. The production of H1N1 vaccine will not affect the production and launch of the seasonal flu vaccine for this coming flu season in 2009, Sinovac said.
Weidong Yin, president and CEO of Sinovac, said: "Having completed the construction of our virus seed bank, our H1N1 vaccine production remains on track and we look forward to initiating clinical trials by the end of next month.
"Sinovac's rapid response to the newly emerged disease outbreak demonstrates the company's resources and capabilities for vaccine production and highlights our commitment to protect the public from virus transmission through the timely supply of vaccines."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
Key support level around the 3.60 area. Closed A/H Friday at 3.70. She sooooo wants to break out. Resistance at the upper trendline and the 4.50 area.
22 Jun Scans. Got some possibly real nice ones here. Lots of them teetering on a very strong support level ready to break out. Stops should be tight as everything is at a strong support. There is one pink included in this based on chart allone. I have no done any research into any of the companies other than charts.
The one that has me most intrigued is the first one.
***THIS BADBOY had a HUGE volume break out and the PPS went up over $1 from 3.62 to 4.63 and closed back at 3.65.
http://stockcharts.com/c-sc/sc?s=KERX&p=D&yr=0&mn=7&dy=0&i=p71375815972&a=171241887&r=175
pinky
Attn all: I just got back from washing my car for the first time with a sponge tech spng.
I picked it up at Walgreens in Honolulu, Hawaii. It was very hard to find as it was not in the car care section. I asked the checker if she sold many of them but she barely spoke English so I didn't get anywhere lol.
Will I use it again? you bet, 5 mins and it was done. Is it cheaper than a car wash? Sure is! Overall i'm very impressed and plan on buying it again.
I suggest all of you who are invested or thinking about investing go purchase the product yourself. How can you INVEST in a company w/out believing in the product.
Have a great day.
That is a sweet stock buddy!
thx for the chart. Dropped my a/h bid to .35
Put in another bid on GFG at .36 for a deal a/h if it gets filled. Shooting star baby!
wtf, GFG dump 3 mins into close lol. Overall not a bad friday. SPNG showing some streangth! GFG sitting right at support. Chart still looks good, it tested .45 today. Hopefully monday we get a strong down and some momo she might break through it. These are my favorite kind of charts. Loniee would you mind doing one up for me on GFG?
THC looking like it might be at a quick friday deal buy...
Could you post the annotated chart for GFG?
jumped into GFG, hoping for a break of .39 and pop, based on chart allone
I got nothing on my scans guys lol. Pathetic. I have several allerts setup but I doubt any of them will hit anytime soon. I guess i'm just gonna watch for bounces off bad news. I missed the 100% bounce on the six flags announcment b/c I got to nervous, WTF. If I would have thought it through it would have been fine.